INM financials

InMed Pharmaceuticals (INM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

INM income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2026–––-$12.99M-3.12
2025$4.94M$1.71M–-$8.16M-8.36
2024$4.60M$1.10M–-$7.68M-20.14
2023$4.14M$1.40M–-$7.95M-65.00
2022$1.09M$543.55K–-$18.60M-663.40
2021–––-$10.20M-759.20